← Back to Bills
HR 3164119th CongressIntroducedHouse

Ensuring Community Access to Pharmacist Services Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Jul 29, 2026
Latest Action Date
May 21, 2026

Latest Action

Ordered to be Reported in the Nature of a Substitute by Voice Vote.

Official Summary

Ensuring Community Access to Pharmacist Services Act This bill provides for permanent coverage under Medicare of certain pharmacist services. Specifically, the bill provides for permanent coverage of testing and treatment services provided by pharmacists relating to (1) COVID-19, influenza, respiratory syncytial virus (RSV), and streptococcal pharyngitis (strep throat); and (2) other public health needs in relation to a declared public health emergency. (Similar authorities were temporarily granted during the COVID-19 public health emergency.) Such services must be provided in accordance with the applicable state laws governing pharmacists' scope of practice.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Ensuring Community Access to Pharmacist Services Act proposes permanent Medicare coverage for certain pharmacist-provided testing and treatment services. These services include those related to COVID-19, influenza, respiratory syncytial virus (RSV), and streptococcal pharyngitis (strep throat), as well as other public health needs during declared public health emergencies. The bill requires that such services be provided in accordance with state laws governing pharmacists' scope of practice. This legislation builds on temporary authorities granted during the COVID-19 public health emergency to maintain access to pharmacist services under Medicare.

Bottom Line

This bill aims to make permanent Medicare coverage for specific pharmacist services that were temporarily authorized during the COVID-19 public health emergency, potentially expanding access to testing and treatment through pharmacists.

Policy Risk Level
🟢 Low
Neutral Risk Assessment
Key Points
  • Provides permanent Medicare coverage for pharmacist services related to COVID-19, influenza, RSV, and strep throat.
  • Extends coverage to pharmacist services addressing other public health needs during declared public health emergencies.
  • Requires compliance with state laws governing pharmacists' scope of practice for service provision.
Who Benefits?

['Medicare beneficiaries who require testing and treatment for specified illnesses.', 'Pharmacists who provide testing and treatment services.', 'Public health systems by potentially improving access to care during health emergencies.']

Potential Concerns

["Implementation challenges in aligning Medicare coverage with varying state laws on pharmacists' scope of practice.", 'Potential costs to Medicare associated with permanent coverage of these services.', 'Oversight mechanisms to ensure appropriate use and quality of pharmacist-provided services.']

Political Context

The bill follows temporary measures enacted during the COVID-19 public health emergency that allowed pharmacists to provide certain testing and treatment services under Medicare. It reflects ongoing legislative efforts to adapt healthcare delivery models and expand access to care through pharmacists, particularly in response to public health emergencies. The bill is currently in process and was ordered to be reported in the nature of a substitute by voice vote.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Increased utilization of pharmacist services may reduce burden on other healthcare providers and facilities.', 'Expanded pharmacist roles could influence state regulatory frameworks and professional practice standards.', 'Improved access to testing and treatment during public health emergencies may enhance early detection and management of infectious diseases.']

GovScope Watchdog Notes

The bill's reliance on state laws for pharmacists' scope of practice introduces variability in implementation and oversight. Transparency on Medicare cost impacts and monitoring mechanisms for service quality and appropriateness will be important for accountability. The absence of the full bill text limits detailed analysis of enforcement and funding provisions.

Passage Likelihood: UnknownConfidence: 85%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready